Global news you need to know before Monday's U.S. stock market opens

Federal Reserve Governor Waller: CEOs say that artificial intelligence will lead to massive layoffs, and the March interest rate decision depends on February labor data.

According to CCTV, the U.S. Customs will stop collecting tariffs deemed illegal by the Supreme Court starting February 24.

According to CCTV, German Chancellor Merz will make an official visit to China from February 25 to 26.

According to Xinhua News Agency, Trump is reported to be considering a "small strike" followed by a "large strike" against Iran.

According to CCTV, due to the risk of U.S. tariffs, the European Union plans to suspend approval of the U.S.-EU trade agreement.

Demand for bearish protection in U.S. stocks has reached a four-year high, with Goldman Sachs traders stating that professional investors are preparing for "some kind of breakthrough."

After a fourfold surge in stock price, SK Hynix promises to continue expanding AI chip production capacity.

In the past 20 days, revenue has exceeded the entire last year! The Dark Side of the Moon has become the fastest domestic company to reach the unicorn status.

Novo Nordisk's U.S. stock fell over 15% in pre-market trading, while Eli Lilly rose over 4%. Novo Nordisk's CagriSema showed less effectiveness in trials compared to Eli Lilly's Zepbound.

Arcellx's U.S. stock rose nearly 78% in pre-market trading, as Gilead Sciences will acquire Arcellx at a price of $115 per share.

Uncertainty surrounding tariff policies clouds the market, with the U.S. dollar and U.S. stock futures declining, spot gold rising above $5,170, and oil prices falling.

Japanese stocks are closed, A-shares are closed, and the Hang Seng Index closed up 2.53%